• 专利标题:   Composition used for, e.g. treating psychiatric disease comprises graphene oxide and phenothiazine and/or phenothiazine.
  • 专利号:   WO2016013009-A1, EP3171877-A1, US2017173036-A1, EP3171877-A4
  • 发明人:   ALFONTA L, RAVENNA Y D, LEV O, GUN J
  • 专利权人:   UNIV BENGURION BG NEGEV TECHNOLOGIES, YISSUM RES DEV CO HEBREW UNIV JERUSALEM
  • 国际专利分类:   A61K031/5415, C01B031/04, C12Q001/54, C07D279/18, C07D279/20
  • 专利详细信息:   WO2016013009-A1 28 Jan 2016 A61K-031/5415 201614 Pages: 64 English
  • 申请详细信息:   WO2016013009-A1 WOIL050749 21 Jul 2015
  • 优先权号:   US026734P, US164805P, US169132P, WOIL050749, US15327465

▎ 摘  要

NOVELTY - A composition comprises graphene oxide and phenothiazine and/or phenothiazine. USE - Composition in the form of tablet or implantable composition used for treating psychiatric disease, inhibiting leukotriene biosynthesis, treating pain, reducing inflammation, and/or treating allergy, asthma and cardiovascular disorder (all claimed). DETAILED DESCRIPTION - INDEPENDENT CLAIMS are included for: (1) a method for extending the release of phenothiazine and/or phenothiazine in a physiological environment comprising combining the phenothiazine and/or phenothiazine and graphene oxide; and (2) a method for converting phenothiazine to phenothiazine comprising contacting graphene oxide and phenothiazine to convert phenothiazine to phenothiazine.